JSP
DXCM icon

Jackson Square Partners’s DexCom DXCM Stock Holding History

Jackson Square Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-628,484
Closed -$80.4M – 92
2022
Q1 		$80.4M Buy
628,484
+1,836
+0.3% +$201K 0.8% 48
2021
Q4 		$84.1M Sell
626,648
-32,776
-5% -$4.71M 0.71% 54
2021
Q3 		$90.2M Sell
659,424
-1,484
-0.2% -$187K 0.57% 61
2021
Q2 		$70.6M Sell
660,908
-174,620
-21% -$16.8M 0.4% 69
2021
Q1 		$75.1M Sell
835,528
-21,064
-2% -$1.98M 0.43% 72
2020
Q4 		$79.2M Sell
856,592
-1,100
-0.1% -$98.2K 0.32% 72
2020
Q3 		$88.4M Buy
857,692
+384,700
+81% +$40.2M 0.41% 63
2020
Q2 		$47.9M Buy
+472,992
New +$42.3M 0.24% 74

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jackson Square Partners's DXCM Position: Q2 2022 in Review

Jackson Square Partners sold out of DexCom (DXCM) in Q2 2022, closing a stake of 628,484 shares — an estimated $80.4M sold.

Jackson Square Partners first reported a position in DXCM in Q2 2020 and held it in 8 quarters. The position peaked at $90.2M in Q3 2021. 797 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Jackson Square Partners reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Jackson Square Partners sold 628,484 DexCom shares in Q2 2022, an estimated $80.4M.
  • Jackson Square Partners first reported a position in DexCom in Q2 2020 and held it in 8 quarters.
  • Jackson Square Partners's DexCom position peaked at $90.2M in Q3 2021.
  • 797 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Jackson Square Partners's 13F filing for Q2 2022, filed 12 Aug 2022.